Skip to content

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو | English

facebook-square
x
envelope

Menu

About Us
Therapeutic Goods
Safety Info
News & Updates
Publications
E-Services
Medicine Availability
Support

Home > News & Updates > Regulatory Updates > Alternative Medicines > Notification F.No.8-3/2019-H&OTC

Notification F.No.8-3/2019-H&OTC

Murtaza Awan Alternative Medicines September 2, 2021December 29, 2021HOTC

Guidelines for manufacturing of Alternative Medicines, Health Products and Probiotic by the DML holders.

notification Download

Share this:

LinkedIn
WhatsApp
Facebook
X

← Conduct Of Clinical Trials Guidelines (v2.0) Stake holders are invited for comments to be submitted within 15 days to email: drap.pharmacy@gmail.com
Notification F.No.4-2/2017-DD (H&OTC) →

Drugs
Medical Devices
Alternative Medicines
Controlled Substances
Licensing and Inspections
Clinical Trials
Pharmacovigilance
Advertisements
General

Quick Navigation

Quick Navigation

Registered Drugs Index
Drug Pricing Index
List of Pharmaceutical Units

Archives

Archives

Drug Regulatory Authority of Pakistan

Islamabad | Karachi | Lahore | Peshawar | Quetta
Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
Website: www.dra.gov.pk

Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan

Contact Us
Report a Problem